Announcements |
AHRQ releases new CME/CE activitiesThe Agency for Healthcare Research and Quality (AHRQ) has released two new continuing medical education/continuing education (CME/CE) modules based on Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease, a comparative effectiveness review developed by the Agency's Effective Health Care Program. The formats include a supplement to the electronic Journal of Managed Care Pharmacy and a video discussion.The modules are available free of charge at http://www.ce.effectivehealthcare.ahrq.gov. A copy of the report and more information on AHRQ's Effective Health Care Program are available at http://www.effectivehealthcare.ahrq.gov. |
Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
No hay comentarios:
Publicar un comentario